Antioxidant defence systems and generation of reactive oxygen species in osteosarcoma cells with defective mitochondria: Effect of selenium

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1797, Issue 6-7, 2010, Pages 890-896

  Wojewoda, Marta ^a   Duszyłski, Jerzy ^a   Szczepanowska, Joanna ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Antioxidant enzyme; Mitochondria; NARP; ROS; Selenium

Indexed keywords

GLUTATHIONE PEROXIDASE; GLYCINE; REACTIVE OXYGEN METABOLITE; SODIUM SELENITE; THIOREDOXIN REDUCTASE; THREONINE;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; HYBRID CELL; MITOCHONDRION; NARP SYNDROME; OSTEOSARCOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; CATALASE; CELL LINE, TUMOR; DNA, MITOCHONDRIAL; HUMANS; HYBRID CELLS; MITOCHONDRIA; MITOCHONDRIAL MYOPATHIES; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MUTATION, MISSENSE; NF-E2-RELATED FACTOR 2; OSTEOSARCOMA; REACTIVE OXYGEN SPECIES; RETINITIS PIGMENTOSA; SELENIUM; SUPEROXIDE DISMUTASE; SYNDROME; THIOREDOXIN-DISULFIDE REDUCTASE;

EID: 77953810397     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2010.01.035     Document Type: Article

References (34)

1. Di Donato S. Multisystem manifestations of mitochondrial disorders. J. Neurol. 2009, 256:693-710.
2. Yang J.L., Weissman L., Bohr V.A., Mattson M.P. Mitochondrial DNA damage and repair in neurodegenerative disorders. DNA Repair (Amst.) 2008, 7:1110-1120.
3. Máximo V., Lima J., Soares P., Sobrinho-Simões M. Mitochondria and cancer. Virchows Arch. 2009, 454:481-495.
4. Jang Y.C., Remmen V.H. The mitochondrial theory of aging: insight from transgenic and knockout mouse models. Exp. Gerontol. 2009, 44(4):256-260.
5. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
6. McKenzie M., Liolitsa D., Hanna M.G. Mitochondrial disease: mutations and mechanisms. Neurochem. Res. 2004, 29:589-600.
7. DiMauro S., Rustin P.A. A critical approach to the therapy of mitochondrial respiratory chain and oxidative phosphorylation diseases. Biochim Biophys Acta 2009, 1792(2):1159-1167.
8. Lenaz G., Baracca A., Carelli V., D'Aurelio M., Sgarbi G., Solaini G. Bioenergetics of mitochondrial diseases associated with mtDNA mutations. Biochim. Biophys. Acta 2004, 1658:89-94.
9. DiMauro S. Mitochondrial diseases. Biochim. Biophys. Acta 2004, 1658:80-88.
10. Tuppen H.A.L., Blakely E.L., Turnbull D.M., Taylor R.W. Mitochondrial DNA mutations and human disease. Biochim. Biophys Acta 2010, 1797(2):113-128.
11. Garcia J.J., Ogilvie I., Robinson B.H., Capaldi R.A. Structure, functioning and assembly of the ATP synthase in cells from patients with the T8993G mitochondrial DNA mutation. Comparison with the enzyme in Rho(0) cells completely lacking mtDNA. J. Biol. Chem. 2000, 275:11075-11081.
12. Sgarbi G., Baracca A., Lenaz G., Valentino L.M., Carelli V., Solaini G. Inefficient coupling between proton transport and ATP synthesis may be the pathogenic mechanism for NARP and Leigh syndrome resulting from the T8993G mutation in mtDNA. Biochem. J. 2006, 395:493-500.
13. Nijtmans L.G., Henderson N.S., Attardi G., Holt I.J. Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 gene. J. Biol. Chem. 2001, 276:6755-6762.
14. Copple I.M., Goldring C.E., Kitteringham N.R., Park B.K. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 2008, 246:24-33.
15. Kobayashi M., Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzym. Regul. 2006, 46:113-140.
16. King M.P., Attardi G. Isolation of human cell lines lacking mitochondrial DNA. Methods Enzymol. 1996, 264:304-313.
17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
18. Holmgren A., Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 1995, 252:199-208.
19. Wardman P. Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic. Biol. Med. 2007, 43:995-1022.
20. Zielonka J., Sarna T., Roberts J.E., Wishart J.F., Kalyanaramana B. Pulse radiolysis and steady-state analyses of the reaction between hydroethidine and superoxide and other oxidants. Arch. Biochem. Biophys. 2006, 456:39-47.
21. Rothe G., Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2', 7'-dichlorofluorescin. J. Leukoc. Biol. 1990, 47:440-448.
22. Arrigo A.P., Firdaus W.J., Mellier G., Moulin M., Paul C., Diaz-latoud Test C. article sample title placed here. Methods 2005, 35:126-138.
23. Szczepanowska J., Zabłocki K., Duszyłski J. Influence of a mitochondrial genetic defect on capacitative calcium entry and mitochondrial organization in the osteosarcoma cells. FEBS Lett. 2004, 578:316-322.
24. Mattiazzi M., Vijayvergija C., Gajewski C.D., DeVivo D.C., Lenaz G., Wiedmann M., Manfredi G. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum. Mol. Genet. 2004, 13:869-879.
25. Geromel V., Kadhom N., Cebalos-Picot I., Ouari O., Polidori A., Munnich A., Rötig A., Rustin P. Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum. Mol. Genet. 2001, 10:1221-1228.
26. Johansson L., Gafvelin G., Arner E.S.J. Selenocysteine in proteins-properties and biotechonogical use. Biochim. Biophys. Acta 2005, 1726:1-13.
27. Arnér E.S.J., Holmgren A. The thioredoxin system in cancer. Semin. Cancer Biol. 2006, 16:420-426.
28. Lee J.W., Gordiyenko N.V., Marchetti M., Tserentsoodol N., Sagher D., Alam S., Weissbach M., Kantorow M., Rodriguez I.R. Gene structure, localization and role in oxidative stress of methionine sulfoxide reductase A (MSRA) in the monkey retina. Exp. Eye Res. 2006, 82:816-827.
29. Moskovitz J., Bar-Noy S., Williams W.M., Requena J., Berlett B.S., Stadtman E.R. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12920-12925.
30. Kim H.Y., Gladyshev V.N. Methionine sulfoxide reductases: selenoprotein forms and roles in antioxidant protein repair in mammals. Biochem. J. 2007, 407:321-329.
31. Pérez V.I., Lew C.M., Cortez L.A., Webb C.R., Rodriguez M., Liu Y., Qi W., Li Y., Chaudhuri A., Van Remmen H., Richardson A., Ikeno Y. Thioredoxin 2 haploinsufficiency in mice results in impaired mitochondrial function and increased oxidative stress. Free Radic. Biol. Med. 2008, 44:882-892.
32. Marchetti M.A., Lee W., Cowell T.L., Wells T.M., Weissbach H., Kantorow M. Silencing of the methionie sulfoxide reductase A gene results in loss of mitochondrial membrane potential and increased ROS production in human lens cells. Exp. Eye Res. 2006, 83:1281-1286.
33. Dassa E.P., Paupe V., Goncalves S., Rustin P. The mtDNA NARP mutation activates the actin-Nrf2 signaling of antioxidant defences. Biochem. Biophys. Res. Commun. 2008, 368:620-624.
34. Ryan M.T., Hoogenraad N.J. Mitochondrial-nuclear communications. Annu. Rev. Biochem. 2007, 76:701-722.